Extracellular Vesicles in Brain Tumor Progression

Cellular and Molecular Neurobiology

Volumn 36, Issue 3, 2016, Pages 383-407

  D’Asti, Esterina ^a   Chennakrishnaiah, Shilpa ^a   Lee, Tae Hoon ^a   Rak, Janusz ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cancer; Exosomes; Extracellular vesicles; Glioblastoma; Medulloblastoma; Oncogenes

Indexed keywords

BIOGENESIS; BRAIN TUMOR; CELL INTERACTION; CELL ORGANELLE; CELL VACUOLE; EXOSOME; GLIOBLASTOMA; HUMAN; MEMBRANE MICROPARTICLE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR GENE; TUMOR GROWTH; VESICULOME; ANIMAL; BRAIN NEOPLASMS; CELL COMMUNICATION; CELL TRANSFORMATION; DISEASE COURSE; GENETICS; METABOLISM; MUTATION; PATHOLOGY;

ANIMALS; BRAIN NEOPLASMS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EXTRACELLULAR VESICLES; HUMANS; MUTATION;

EID: 84961211556     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-015-0296-1     Document Type: Review

References (285)

1. Abd Elmageed ZY, Yang Y, Thomas R et al (2014) Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes. Stem Cells 32:983–997
2. Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7:834–846
3. Al-Nedawi K, Meehan B, Micallef J et al (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10:619–624
4. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J (2009a) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 106:3794–3799
5. Al-Nedawi K, Meehan B, Rak J (2009b) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8:2014–2018
6. Alvarez-Erviti L, Seow Y, Yin H et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341–345
7. Alves TR, Lima FR, Kahn SA et al (2011) Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. Life Sci 89:532–539
8. Andoniadou CL, Matsushima D, Mousavy Gharavy SN et al (2013) Sox2(+) stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell 13:433–445
9. Antonyak MA, Li B, Boroughs LK et al (2011) Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 108:4852–4857
10. Appin CL, Brat DJ (2015) Biomarker-driven diagnosis of diffuse gliomas. Mol Aspects Med 45:87–96
11. Arscott WT, Tandle AT, Zhao S et al (2013) Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Transl Oncol 6:638–648
12. Atai NA, Balaj L, van Veen H et al (2013) Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol 115:343–351
13. Atay S, Banskota S, Crow J et al (2014) Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc Natl Acad Sci USA 111:711–716
14. Atkin-Smith GK, Tixeira R, Paone S et al (2015) A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure. Nat Commun 6:7439
15. Attwell D, Buchan AM, Charpak S et al (2010) Glial and neuronal control of brain blood flow. Nature 468:232–243
16. Balaj L, Lessard R, Dai L et al (2011) Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2:180
17. Balaj L, Chen W, Liau LM et al (2012) BEAMing qRT-PCR analysis of IDH1 mutant in tumor microvesicles. J Extracell Vesicles 1:30
18. Balaj L, Atai NA, Chen W et al (2015) Heparin affinity purification of extracellular vesicles. Sci Rep 5:10266
19. Barault L, Amatu A, Bleeker FE et al (2015) Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. Ann Oncol 26(9):1994–1999
20. Bebawy M, Combes V, Lee E et al (2009) Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 23:1643–1649
21. Belting M, Wittrup A (2008) Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J Cell Biol 183(7):1187–1191
22. Bergsmedh A, Szeles A, Henriksson M et al (2001) Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci USA 98:6407–6411
23. Berridge MV, Dong L, Neuzil J (2015) Mitochondrial DNA in tumor initiation, progression, and metastasis: role of horizontal mtDNA transfer. Cancer Res 75:3203–3208
24. Bianco F, Perrotta C, Novellino L et al (2009) Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J 28:1043–1054
25. Biernat W, Huang H, Yokoo H, Kleihues P, Ohgaki H (2004) Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas. Brain Pathol 14:131–136
26. Black WC, Welch HG (1993) Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 328:1237–1243
27. Bobrie A, Thery C (2013) Exosomes and communication between tumours and the immune system: are all exosomes equal? Biochem Soc Trans 41:263–267
28. Bobrie A, Krumeich S, Reyal F et al (2012) Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 72:4920–4930
29. Boccaccio C, Sabatino G, Medico E et al (2005) The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 434:396–400
30. Boelens MC, Wu TJ, Nabet BY et al (2014) Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell 159:499–513
31. Bolukbasi MF, Mizrak A, Ozdener GB et al (2012) miR-1289 and “Zipcode”-like sequence enrich mRNAs in microvesicles. Mol Ther Nucleic Acids 1:e10. doi:10.1038/mtna.2011.2
32. Bonavia R, Inda MM, Cavenee WK, Furnari FB (2011) Heterogeneity maintenance in glioblastoma: a social network. Cancer Res 71:4055–4060
33. Bondy ML, Scheurer ME, Malmer B et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113:1953–1968
34. Bouck N, Stellmach V, Hsu SC (1996) How tumors become angiogenic. Adv Cancer Res 69:135–174
35. Bourkoula E, Mangoni D, Ius T et al (2014) Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas. Stem Cells 32:1239–1253
36. Bozzuto G, Toccacieli L, Mazzoleni S et al (2014) Brain tumor stem cell dancing. Ann Ist Super Sanita 50:286–290
37. Brash DE (2015) Cancer. Preprocancer. Science 348:867–868
38. Brat DJ, Van Meir EG (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 84:397–405
39. Brat DJ, Verhaak RG, Aldape KD et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498
40. Brockmann MA, Bender B, Plaxina E et al (2011) Differential effects of tumor-platelet interaction in vitro and in vivo in glioblastoma. J Neurooncol 105:45–56
41. Bronisz A, Wang Y, Nowicki MO et al (2014) Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res 74:738–750
42. Burrell K, Singh S, Jalali S, Hill RP, Zadeh G (2014) VEGF regulates region-specific localization of perivascular bone marrow-derived cells in glioblastoma. Cancer Res 74:3727–3739
43. Bussolati B, Grange C, Camussi G (2011) Tumor exploits alternative strategies to achieve vascularization. FASEB J 25:2874–2882
44. Cai J, Han Y, Ren H et al (2013) Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol 5:227–238
45. Cai J, Wu G, Tan X et al (2014) Transferred BCR/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice. PLoS One 9:e105200
46. Caine GD, Weller RO, Davis BE, Cox S (1980) Mechanisms of uptake and the fate of serum proteins and horseradish peroxidase in cultured human glioma cells. A light- and electron-immunocytochemical study. Acta Neuropathol 52:169–177
47. Camacho L, Guerrero P, Marchetti D (2013) MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PLoS One 8:e73790
48. Carmeliet P, Ferreira V, Breier G et al (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435–439
49. Castellana D, Zobairi F, Martinez MC et al (2009) Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 69:785–793
50. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ (2010) Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 190:1079–1091
51. Chaput N, Thery C (2011) Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 33:419–440
52. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H (2012) The brain tumor microenvironment. Glia 60:502–514
53. Chen C, Skog J, Hsu CH et al (2010) Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10:505–511
54. Chen J, Li Y, Yu TS et al (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522–526
55. Chen WW, Balaj L, Liau LM et al (2013) BEAMing and droplet digital PCR analysis of mutant IDH1 mRNA in glioma patient serum and cerebrospinal fluid extracellular vesicles. Mol Ther Nucleic Acids 2:e109
56. Cheng L, Huang Z, Zhou W et al (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153:139–152
57. Chevillet JR, Kang Q, Ruf IK et al (2014) Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA 111:14888–14893
58. Chinot OL, Reardon DA (2014) The future of antiangiogenic treatment in glioblastoma. Curr Opin Neurol 27:675–682
59. Chittiboina P, Connor DE Jr, Caldito G et al (2012) Occult tumors presenting with negative imaging: analysis of the literature. J Neurosurg 116:1195–1203
60. Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M (2013) Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci USA 110:17380–17385
61. Ciravolo V, Huber V, Ghedini GC et al (2012) Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol 227:658–667
62. Colombo M, Raposo G, Thery C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289
63. Corrado C, Raimondo S, Saieva L et al (2014) Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. Cancer Lett 348:71–76
64. Cossetti C, Smith JA, Iraci N et al (2012) Extracellular membrane vesicles and immune regulation in the brain. Front Physiol 3:117
65. Costa-Silva B, Aiello NM, Ocean AJ et al (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17:816–826
66. Crowley E, Di NF, Loupakis F, Bardelli A (2013) Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol 10:472–484
67. Das J, Ivanov I, Montermini L et al (2015) An electrochemical clamp assay for direct, rapid analysis of circulating nucleic acids in serum. Nat Chem 7:569–575
68. D’Asti E, Huang A, Rak J (2012) Downregulation of tissue factor (TF) in medulloblastoma cells expressing miR-520g. In: Proceedings of Keystone Syposia, Snowmass, CO, March 30, 2012
69. D’Asti E, Kool M, Pfister SM, Rak J (2014) Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk. J Thromb Haemost 12:1838–1849
70. D’Asti E, Huang A, Kool M et al (2016) Tissue factor regulation by miR-520g in primitive neuronal brain tumor cells: a possible link between oncomirs and the vascular tumor microenvironment. Am J Pathol 186:446–459
71. de Vrij J, Maas S, Kwappenberg K et al (2015) Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer 137:1630–1642
72. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604–1611
73. Demory BM, Higginbotham JN, Franklin JL et al (2013) Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics 12:343–355
74. Di Vizio D, Kim J, Hager MH et al (2009) Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 69:5601–5609
75. Dow LE, O’Rourke KP, Simon J et al (2015) Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell 161:1539–1552
76. Eckel-Passow JE, Lachance DH, Molinaro AM et al (2015) Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499–2508
77. EL Andaloussi AS, Mager I, Breakefield XO, Wood MJ (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347–357
78. El-Andaloussi S, Lee Y, Lakhal-Littleton S et al (2012) Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7:2112–2126
79. Epple LM, Griffiths SG, Dechkovskaia AM et al (2012) Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS One 7:e42064
80. Escrevente C, Keller S, Altevogt P, Costa J (2011) Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer 11:108
81. Falchi AM, Sogos V, Saba F et al (2013) Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP. Histochem Cell Biol 139:221–231
82. Fang Y, Garnier D, Lee TH et al (2015) PML–RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells. Angiogenesis 19(1):25–38
83. Faury D, Nantel A, Dunn SE et al (2007) Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. J Clin Oncol 25:1196–1208
84. Finak G, Bertos N, Pepin F et al (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14:518–527
85. Fitzner D, Schnaars M, van Rossum RD et al (2011) Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci 124:447–458
86. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273–286
87. Fong MY, Zhou W, Liu L et al (2015) Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 17:183–194
88. Foote MB, Papadopoulos N, Diaz LA Jr (2015) Genetic classification of gliomas: refining histopathology. Cancer Cell 28:9–11
89. Franklin JL, Beckler MD, Higginbotham JN, Coffey RJ Jr (2012) Exosomes from mutant KRAS cells transfer KRAS and transform wild type KRAS recipient cells. J Extracell Vesicles 1:26
90. Friedmann-Morvinski D, Bushong EA, Ke E et al (2012) Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 338:1080–1084
91. Fruhbeis C, Frohlich D, Kuo WP, Kramer-Albers EM (2013a) Extracellular vesicles as mediators of neuron-glia communication. Front Cell Neurosci 7:182
92. Fruhbeis C, Frohlich D, Kuo WP et al (2013b) Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol 11:e1001604
93. Gabriel K, Ingram A, Austin R et al (2013) Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer. PLoS One 8:e70047
94. Gan HK, Cvrljevic AN, Johns TG (2013) The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered. FEBS J 280:5350–5370
95. Garcia-Barros M, Paris F, Cordon-Cardo C et al (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155–1159
96. Garcia-Olmo DC, Dominguez C, Garcia-Arranz M et al (2010) Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res 70:560–567
97. Garnier D, Magnus N, Lee TH et al (2012) Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem 287:43565–43572
98. Garnier D, Magnus N, Meehan B, Kislinger T, Rak J (2013a) Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Exp Cell Res 319:2747–2757
99. Garnier D, Jabado N, Rak J (2013b) Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours. Proteomics 13:1595–1607
100. Geddings JE, Mackman N (2013) Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122:1873–1880
101. Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892
102. Ghajar CM, Peinado H, Mori H et al (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15:807–817
103. Ghosh AK, Secreto CR, Knox TR et al (2010) Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 115:1755–1764
104. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11:1143–1149
105. Gilbertson RJ, Rich JN (2007) Making a tumour’s bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7:733–736
106. Gould SJ, Raposo G (2013) As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles. doi:10.3402/jev.v2i0.20389
107. Graner MW, Alzate O, Dechkovskaia AM et al (2009) Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 23:1541–1557
108. Grange C, Tapparo M, Collino F et al (2011) Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71:5346–5356
109. Guescini M, Genedani S, Stocchi V, Agnati LF (2010) Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J Neural Transm 117:1–4
110. Gyorgy B, Szabo TG, Pasztoi M et al (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68:2667–2688
111. Gyorgy B, Hung ME, Breakefield XO, Leonard JN (2015) Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol 55:439–464
112. Harding C, Heuser J, Stahl P (1983) Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97:329–339
113. Harshyne LA, Hooper KM, Andrews EG et al (2015) Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm. Cancer Immunol Immunother 64:299–309
114. Hendrix A, Maynard D, Pauwels P et al (2010) Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst 102:866–880
115. Heppner GH (1989) Tumor cell societies. J Natl Cancer Inst 81:648–649
116. Heyn C, Ronald JA, Ramadan SS et al (2006) In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med 56:1001–1010
117. Hochberg F, Toniolo P, Cole P (1984) Head trauma and seizures as risk factors of glioblastoma. Neurology 34:1511–1514
118. Hochberg FH, Atai NA, Gonda D et al (2014) Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science. Expert Rev Mol Diagn 14:439–452
119. Hoelzinger DB, Demuth T, Berens ME (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99:1583–1593
120. Holmgren L (2010) Horizontal gene transfer: you are what you eat. Biochem Biophys Res Commun 396:147–151
121. Holmgren L, Szeles A, Rajnavolgyi E et al (1999) Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93:3956–3963
122. Hood JL, San RS, Wickline SA (2011) Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 71:3792–3801
123. Hsu C, Morohashi Y, Yoshimura S et al (2010) Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol 189:223–232
124. Inda MM, Bonavia R, Mukasa A et al (2010) Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev 24:1731–1745
125. Italiano JE Jr, Richardson JL, Patel-Hett S et al (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111:1227–1233
126. Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M, Ratajczak MZ (2006) Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion 46:1199–1209
127. Jia S, Zocco D, Samuels ML et al (2014) Emerging technologies in extracellular vesicle-based molecular diagnostics. Expert Rev Mol Diagn 14:307–321
128. Johnstone RM (2006) Exosomes biological significance: a concise review. Blood Cells Mol Dis 36:315–321
129. Kahlert C, Melo SA, Protopopov A et al (2014) Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 289:3869–3875
130. Kalra H, Simpson RJ, Ji H et al (2012) Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 10:e1001450
131. Kanada M, Bachmann MH, Hardy JW et al (2015) Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci USA 112:E1433–E1442
132. Katakowski M, Buller B, Zheng X et al (2013) Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 335:201–204
133. Kieran MW, Walker D, Frappaz D, Prados M (2010) Brain tumors: from childhood through adolescence into adulthood. J Clin Oncol 28:4783–4789
134. Koch R, Demant M, Aung T et al (2014) Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma. Blood 123:2189–2198
135. Kool M, Korshunov A, Remke M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123:473–484
136. Kosaka N, Iguchi H, Yoshioka Y et al (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:17442–17452
137. Kravchenko-Balasha N, Wang J, Remacle F, Levine RD, Heath JR (2014) Glioblastoma cellular architectures are predicted through the characterization of two-cell interactions. Proc Natl Acad Sci USA 111:6521–6526
138. Kucharzewska P, Christianson HC, Welch JE et al (2013) Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci USA 110:7312–7317
139. Lai CP, Breakefield XO (2012) Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol 3:228
140. Lai CP, Tannous BA, Breakefield XO (2014a) Noninvasive in vivo monitoring of extracellular vesicles. Methods Mol Biol 1098:249–258
141. Lai CP, Mardini O, Ericsson M et al (2014b) Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano 8:483–494
142. Lai CP, Kim EY, Badr CE et al (2015) Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat Commun 6:7029
143. Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN (2015) Cancer stem cells in glioblastoma. Genes Dev 29:1203–1217
144. Lazaro-Ibanez E, Sanz-Garcia A, Visakorpi T et al (2014) Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes. Prostate 74:1379–1390
145. Lee T-H, Rak J (2011) Unpublished observation
146. Lee TH, D’Asti E, Magnus N et al (2011) Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’. Semin Immunopathol 33:455–467
147. Lee T-H, Montermini L, Meehan B, et al. (2013) Collateral cell transformation by exosome-like extracellular vesicles harbouring mutant H-ras Oncogene. J Extracell Vesicles (ISEV 2013 - Meeting Abstracts) 2013
148. Lee TH, Chennakrishnaiah S, Audemard E et al (2014) Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells. Biochem Biophys Res Commun 451:295–301
149. Leith J, Michelson TS, Faulkner LE, Bliven SF (1987) Growth properties of artificial heterogenous human colon tumors. Cancer Res 47:1045–1051
150. Lespagnol A, Duflaut D, Beekman C et al (2008) Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ 15:1723–1733
151. Li B, Antonyak MA, Zhang J, Cerione RA (2012) RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 31:4740–4749
152. Lim JW, Mathias RA, Kapp EA et al (2012) Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4. Electrophoresis 33:1873–1880
153. Lo Cicero A, Schiera G, Proia P et al (2011) Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes. Int J Oncol 39:1353–1357
154. Lorger M (2012) Tumor microenvironment in the brain. Cancers (Basel) 4:218–243
155. Louveau A, Smirnov I, Keyes TJ et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337–341
156. Luga V, Zhang L, Viloria-Petit AM et al (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151:1542–1556
157. Macarthur KM, Kao GD, Chandrasekaran S et al (2014) Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res 74:2152–2159
158. Magnus N, Gerges N, Jabado N, Rak J (2013) Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype. J Thromb Haemost 11:1197–1200
159. Magnus N, Garnier D, Meehan B et al (2014a) Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations. Proc Natl Acad Sci USA 111:3544–3549
160. Magnus N, D’Asti E, Meehan B, Garnier D, Rak J (2014b) Oncogenes and the coagulation system–forces that modulate dormant and aggressive states in cancer. Thromb Res 133(Suppl 2):S1–S9
161. Maguire CA, Balaj L, Sivaraman S et al (2012) Microvesicle-associated AAV vector as a novel gene delivery system. Mol Ther 20:960–971
162. Maguire JE, Silva M, Nguyen KC et al (2015) Myristoylated CIL-7 regulates ciliary extracellular vesicle biogenesis. Mol Biol Cell 26:2823–2832
163. Mahmoudi K, Ezrin A, Hadjipanayis C (2015) Small extracellular vesicles as tumor biomarkers for glioblastoma. Mol Aspects Med 45:97–102
164. Mao P, Joshi K, Li J et al (2013) Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci USA 110:8644–8649
165. Martincorena I, Roshan A, Gerstung M et al (2015) Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348:880–886
166. Marzesco AM (2013) Prominin-1-containing membrane vesicles: origins, formation, and utility. Adv Exp Med Biol 777:41–54. doi:10.1007/978-1-4614-5894-4_3
167. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ (2011) ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 40:D1241–D1244
168. Melo SA, Sugimoto H, O’Connell JT et al (2014) Cancer exosomes perform cell-independent MicroRNA biogenesis and promote tumorigenesis. Cancer Cell 26:707–721
169. Melo SA, Luecke LB, Kahlert C et al (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523:177–182
170. Minciacchi VR, Freeman MR, Di VD (2015) Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol 40:41–51
171. Miranda A, Funes JM, Sanchez N et al (2015) Oncogenic transformation can orchestrate immune evasion and inflammation in human mesenchymal stem cells independently of extrinsic immune-selective pressure. Cancer Res 75(15):3032–3042
172. Mizrak A, Bolukbasi MF, Ozdener GB et al (2013) Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther 21:101–108
173. Mohankumar KM, Currle DS, White E et al (2015) An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes. Nat Genet 47:878–887
174. Montermini L, Meehan B, Garnier D et al (2015) Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content. J Biol Chem 290(40):24534–24546
175. Moore PS, Chang Y (2010) Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 10:878–889
176. Morrison HA, Dionne H, Rusten TE et al (2008) Regulation of early endosomal entry by the Drosophila tumor suppressors Rabenosyn and Vps45. Mol Biol Cell 19:4167–4176
177. Morrison LC, McClelland R, Aiken C et al (2013) Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes. Neoplasia 15:384–398
178. Mulcahy LA, Pink RC, Carter DR (2014) Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. doi:10.3402/jev.v3.24641
179. Muller C, Holtschmidt J, Auer M et al (2014) Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 6:247ra101
180. Muller L, Muller-Haegele S, Mitsuhashi M et al (2015) Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival. Oncoimmunology 4:e1008347
181. Mullighan CG, Phillips LA, Su X et al (2008) Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322:1377–1380
182. Muralidharan-Chari V, Clancy J, Plou C et al (2009) ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 19:1875–1885
183. Nakano I, Garnier D, Minata M, Rak J (2015) Extracellular vesicles in the biology of brain tumour stem cells—implications for inter-cellular communication, therapy and biomarker development. Semin Cell Dev Biol 40:17–26
184. Nam KT, Lee HJ, Smith JJ et al (2010) Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J Clin Invest 120:840–849
185. Noerholm M, Balaj L, Limperg T et al (2012) RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 12:22
186. Northcott PA, Korshunov A, Pfister SM, Taylor MD (2012) The clinical implications of medulloblastoma subgroups. Nat Rev Neurol 8:340–351
187. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23–28
188. Oh EY, Christensen SM, Ghanta S et al (2015) Extensive rewiring of epithelial-stromal co-expression networks in breast cancer. Genome Biol 16:128
189. Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19:764–772
190. Ono M, Kosaka N, Tominaga N et al (2014) Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal 7:ra63
191. Ostenfeld MS, Jeppesen DK, Laurberg JR et al (2014) Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res 74:5758–5771
192. Ostrowski M, Carmo NB, Krumeich S et al (2010) Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12:19–30
193. Osswald M, Jung E, Sahm F et al (2015) Brain tumour cells interconnect to a functional and resistant network. Nature 528(7580):93–98
194. Pan BT, Johnstone RM (1983) Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33:967–978
195. Parker NR, Khong P, Parkinson JF, Howell VM, Wheeler HR (2015) Molecular heterogeneity in glioblastoma: potential clinical implications. Front Oncol 5:55
196. Patel AP, Tirosh I, Trombetta JJ et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396–1401
197. Peinado H, Aleckovic M, Lavotshkin S et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18:833–891
198. Perry JR (2012) Thromboembolic disease in patients with high-grade glioma. Neuro Oncol 14(Suppl 4):iv73–iv80. doi:10.1093/neuonc/nos197
199. Phillips HS, Kharbanda S, Chen R et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157–173
200. Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21:157–171
201. Pilzer D, Fishelson Z (2005) Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis. Int Immunol 17:1239–1248
202. Poste G, Nicolson GL (1980) Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77:399–403
203. Prada I, Furlan R, Matteoli M, Verderio C (2013) Classical and unconventional pathways of vesicular release in microglia. Glia 61:1003–1017
204. Putz U, Howitt J, Doan A et al (2012a) The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal 5:ra70
205. Putz U, Doan A, Tan S-S (2012b) The tumor suppressor PTEN is transported in exosomes for extracellular phosphatase activity. J Extracell Vesicles 1:78
206. Raab-Traub N (2012) Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2:453–458
207. Rajendran L, Bali J, Barr MM et al (2014) Emerging roles of extracellular vesicles in the nervous system. J Neurosci 34:15482–15489
208. Rak J (1989) Possible role of tumour stem - end cell interaction in metastasis. Med Hypoth 29:17–19
209. Rak J (2006) Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis? Med Hypotheses 66:601–604
210. Rak J (2009) Ras oncogenes and tumour vascular interface. In: Thomas-Tikhonenko A (ed) Cancer genome and tumor microenvironment. Springer, New York, pp 133–165
211. Rak J (2013) Extracellular vesicles—biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol 4:21
212. Rak J, Mitsuhashi Y, Bayko L et al (1995) Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55:4575–4580
213. Ramnarain DB, Park S, Lee DY et al (2006) Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res 66:867–874
214. Raposo G, Nijman HW, Stoorvogel W et al (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183:1161–1172
215. Ratajczak J, Miekus K, Kucia M et al (2006a) Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:847–856
216. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ (2006b) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:1487–1495
217. Reardon DA, Schuster JM, Tran DD et al (2015) 107 ReACT: overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma. Neurosurgery 62(Suppl 1):198–199
218. Redzic JS, Balaj L, van der Vos KE, Breakefield XO (2014) Extracellular RNA mediates and marks cancer progression. Semin Cancer Biol 28:14–23
219. Ridder K, Keller S, Dams M et al (2014) Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol 12:e1001874
220. Ridder K, Sevko A, Heide J et al (2015) Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment. Oncoimmunology 19(4):e1008371
221. Robbins PD, Morelli AE (2014) Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14:195–208
222. Roccaro AM, Sacco A, Maiso P et al (2013) BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 123:1542–1555
223. Santiago-Dieppa DR, Steinberg J, Gonda D et al (2014) Extracellular vesicles as a platform for ‘liquid biopsy’ in glioblastoma patients. Expert Rev Mol Diagn 14:819–825
224. Sartori MT, Della PA, Ballin A et al (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 104:225–231
225. Schmitz N, Wu HS (2015) Advances in the treatment of secondary CNS lymphoma. J Clin Oncol 33(33):3851–3853
226. Schnoor R, Maas SL, Broekman ML (2015) Heparin in malignant glioma: review of preclinical studies and clinical results. J Neurooncol 124:151–156
227. Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226–231
228. Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426–437
229. Seoane J, De Mattos-Arruda L (2014) Escaping out of the brain. Cancer Discov 4:1259–1261
230. Shao H, Chung J, Balaj L et al (2012) Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med 18:1835–1840
231. Shao H, Chung J, Lee K et al (2015) Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun 6:6999
232. Sheldon H, Heikamp E, Turley H et al (2010) New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 116:2385–2394
233. Shen B, Wu N, Yang JM, Gould SJ (2011) Protein targeting to exosomes/microvesicles by plasma membrane anchors. J Biol Chem 286:14383–14395
234. Shimoda M, Principe S, Jackson HW et al (2014) Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state. Nat Cell Biol 16(9):889–901
235. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401
236. Skog J, Wurdinger T, van Rijn S et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470–1476
237. Snuderl M, Fazlollahi L, Le LP et al (2011) Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20:810–817
238. Sottoriva A, Spiteri I, Piccirillo SG et al (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 110:4009–4014
239. Souza-Schorey C, Clancy JW (2012) Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 26:1287–1299
240. Sowers JL, Johnson KM, Conrad C, Patterson JT, Sowers LC (2014) The role of inflammation in brain cancer. Adv Exp Med Biol 816:75–105
241. Sparmann A, Bar-Sagi D (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6:447–458
242. Steeg PS, Camphausen KA, Smith QR (2011) Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 11:352–363
243. Stiles CD, Rowitch DH (2008) Glioma stem cells: a midterm exam. Neuron 58:832–846
244. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
245. Sturm D, Bender S, Jones DT et al (2014) Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14:92–107
246. Sullivan JP, Nahed BV, Madden MW et al (2014) Brain tumor cells in circulation are enriched for mesenchymal gene expression. Cancer Discov 4:1299–1309
247. Svensson KJ, Kucharzewska P, Christianson HC et al (2011) Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci USA 108:13147–13152
248. Svensson KJ, Christianson HC, Wittrup A et al (2013) Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem 288:17713–17724
249. Tani E, Nakano M, Itagaki T, Fukumori T (1978) Cell membrane structure of human giant-celled glioblastoma. Acta Neuropathol 19:61–65
250. Taraboletti G, D’Ascenzo S, Giusti I et al (2006) Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 8:96–103
251. Tauro BJ, Mathias RA, Greening DW et al (2013) Oncogenic H-Ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Mol Cell Proteomics 12:2148–2159
252. Tehrani M, Friedman TM, Olson JJ, Brat DJ (2008) Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma. Brain Pathol 18:164–171
253. Thakur BK, Zhang H, Becker A et al (2014) Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 24:766–769
254. Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9:581–593
255. Tominaga N, Kosaka N, Ono M et al (2015) Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun 6:6716
256. Trajkovic K, Hsu C, Chiantia S et al (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244–1247
257. Travis LB, Demark WW, Allan JM, Wood ME, Ng AK (2013) Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol 10:289–301
258. Ung TH, Madsen HJ, Hellwinkel JE, Lencioni AM, Graner MW (2014) Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways. Cancer Sci 105:1384–1392
259. Valadi H, Ekstrom K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–659
260. van der Vos KE, Balaj L, Skog J, Breakefield XO (2011) Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol 31:949–959
261. Van der Vos KE, Abels ER, Zhang X et al (2015) Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. Neuro Oncol 18(1):58–69
262. Veliz I, Loo Y, Castillo O et al (2015) Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future? Ann Transl Med 3:7–5839
263. Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110
264. Verweij FJ, van Eijndhoven MA, Hopmans ES et al (2011) LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-kappaB activation. EMBO J 30:2115–2129
265. Wang JY, Bettegowda C (2015) Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies. J Neurooncol 123:373–383
266. Webber J, Yeung V, Clayton A (2015) Extracellular vesicles as modulators of the cancer microenvironment. Semin Cell Dev Biol 40:27–34
267. Welton JL, Khanna S, Giles PJ et al (2010) Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics 9:1324–1338
268. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507
269. Wheeler DB, Zoncu R, Root DE, Sabatini DM, Sawyers CL (2015) Identification of an oncogenic RAB protein. Science 350(6257):211–217
270. Wolfers J, Lozier A, Raposo G et al (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297–303
271. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278–299
272. Wu X, Northcott PA, Dubuc A et al (2012) Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482:529–533
273. Wurdinger T, Tannous BA, Saydam O et al (2008) miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14:382–393
274. Wurdinger T, Deumelandt K, van der Vliet HJ, Wesseling P, de Gruijl TD (2014) Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. Biochim Biophys Acta 1846:560–575
275. Xie L, Kang H, Xu Q et al (2013) Sleep drives metabolite clearance from the adult brain. Science 342:373–377
276. Yan T, Mizutani A, Chen L et al (2014) Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles. J Cancer 5:572–584
277. Yang M, Li Y, Chilukuri K et al (2011) L1 stimulation of human glioma cell motility correlates with FAK activation. J Neurooncol 105:27–44
278. Yoon JH, Kim J, Kim KL et al (2014) Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors. Proteomics 14:1494–1502
279. Yu JL, May L, Lhotak V et al (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105:1734–1741
280. Yu X, Harris SL, Levine AJ (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66:4795–4801
281. Zhang L, Zhang S, Yao J et al (2015) Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527(7576):100–104
282. Zhu Y, Parada LF (2002) The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2:616–626
283. Zhu X, You Y, Li Q et al (2014) BCR-ABL1-positive microvesicles transform normal hematopoietic transplants through genomic instability: implications for donor cell leukemia. Leukemia 28:1666–1675
284. Zoller M (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 9:40–55
285. Zomer A, Maynard C, Verweij FJ et al (2015) In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161:1046–1057